Ingenix

Ingenix

Private
WarsawHealthcare & Life Scienceshttps://ingenix.ai/

Last Round

Seed

Jun 3, 2026

Total Funding Raised

$15.1M

Momentum Score

25 /100

Company Overview

Ingenix is a biotechnology, artificial intelligence (AI), and software as a service (SaaS) company that provides a generative AI co-pilot for simulating clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Foundation

Keywords

clinical trial simulationin-silico trialsAI co-pilotBiological Reasoning Enginemultimodal AIAI for pharmadrug development AIgenerative AIclinical outcome predictionModality Fusionclinical trial digital twinAI foundation modelbiotech AIcomputational biologyadverse event predictiondrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ingenix Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ingenix Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJun 3, 2026

Key People

Founding team and executive leadership

Piotr Surma

CEO

Executive Team

Ingenix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    $15M round led by Sofinnova Partners

  • Feb 20, 2026

    Grew 55% QoQ from 20 to 31 employees.

Ingenix Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ingenix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ingenix's valuation, stock price, and market status.

Firmographic Details

HeadquartersWarsaw
Employee Range33
Year Founded2023
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.